Dialog beyond the Grave: Necrosis in the Tumor Microenvironment and Its Contribution to Tumor Growth

Damage-associated molecular patterns (DAMPs) are endogenous molecules released from the necrotic cells dying after exposure to various stressors. After binding to their receptors, they can stimulate various signaling pathways in target cells. DAMPs are especially abundant in the microenvironment of malignant tumors and are suspected to influence the behavior of malignant and stromal cells in multiple ways often resulting in promotion of cell proliferation, migration, invasion, and metastasis, as well as increased immune evasion. This review will start with a reminder of the main features of cell necrosis, which will be compared to other forms of cell death. Then we will summarize the various methods used to assess tumor necrosis in clinical practice including medical imaging, histopathological examination, and/or biological assays. We will also consider the importance of necrosis as a prognostic factor. Then the focus will be on the DAMPs and their role in the tumor microenvironment (TME). We will address not only their interactions with the malignant cells, frequently leading to cancer progression, but also with the immune cells and their contribution to immunosuppression. Finally, we will emphasize the role of DAMPs released by necrotic cells in the activation of Toll-like receptors (TLRs) and the possible contributions of TLRs to tumor development. This last point is very important for the future of cancer therapeutics since there are attempts to use TLR artificial ligands for cancer therapeutics.

[1]  Zichao Guo,et al.  Excessive HSP70/TLR2 activation leads to remodeling of the tumor immune microenvironment to resist chemotherapy sensitivity of mFOLFOX in colorectal cancer. , 2022, Clinical immunology.

[2]  Ihor O. Arkhypov,et al.  HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling , 2022, Journal for ImmunoTherapy of Cancer.

[3]  Han Liu,et al.  Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter study , 2022, Hepatology International.

[4]  Tao Li,et al.  Targeting Heat-Shock Protein 90 in Cancer: An Update on Combination Therapy , 2022, Cells.

[5]  W. Linehan,et al.  Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell Carcinoma , 2022, Journal of Experimental & Clinical Cancer Research.

[6]  David Killock HSP90 inhibition improves GIST survival , 2022, Nature Reviews Clinical Oncology.

[7]  Qiushi Ren,et al.  A Hybrid Imaging Platform(CT/PET/FMI) for Evaluating Tumor Necrosis and Apoptosis in Real-Time , 2022, Frontiers in Oncology.

[8]  R. Sýkora,et al.  Toll-like receptor 3 (TLR3) overexpression induces invasion of prostate cancer cells, whereas its activation triggers apoptosis. , 2022, The American journal of pathology.

[9]  A. Zarbock,et al.  The Fatal Circle of NETs and NET-Associated DAMPs Contributing to Organ Dysfunction , 2022, Cells.

[10]  S. Eccles,et al.  HMGB1 mediates invasion and PD-L1 expression through RAGE-PI3K/AKT signaling pathway in MDA-MB-231 breast cancer cells , 2022, BMC cancer.

[11]  Ming-ze Ma,et al.  HMGB1 overexpression promotes a malignant phenotype and radioresistance in ESCC , 2022, Journal of Cancer.

[12]  J. Seo,et al.  A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response , 2022, Oncogene.

[13]  T. Du,et al.  Secreted HSP90α-LRP1 Signaling Promotes Tumor Metastasis and Chemoresistance in Pancreatic Cancer , 2022, International journal of molecular sciences.

[14]  G. Kroemer,et al.  Targeting HSP90 sensitizes pancreas carcinoma to PD-1 blockade , 2022, Oncoimmunology.

[15]  Y. Fujii,et al.  HSP90 inhibition overcomes resistance to molecular targeted therapy in BRAFV600E mutant high-grade glioma. , 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  G. Mills,et al.  Anti-tumor Activity of a Mitochondrial Targeted HSP90 Inhibitor in Gliomas. , 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  M. Kumar,et al.  SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer , 2022, Cell reports. Medicine.

[18]  Zejun Lu,et al.  HSP90 promotes radioresistance of cervical cancer cells via reducing FBXO6‐mediated CD147 polyubiquitination , 2022, Cancer science.

[19]  Nicolò Riggi,et al.  Necrotic debris and STING exert therapeutically relevant effects on tumor cholesterol homeostasis , 2022, Life Science Alliance.

[20]  L. Conti,et al.  Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy , 2021, Oncoimmunology.

[21]  Y. Seimbille,et al.  In Vivo Evaluation of Gallium-68-Labeled IRDye800CW as a Necrosis Avid Contrast Agent in Solid Tumors , 2021, Contrast media & molecular imaging.

[22]  S. Raimondo,et al.  Tumor-Derived Small Extracellular Vesicles Induce Pro-Inflammatory Cytokine Expression and PD-L1 Regulation in M0 Macrophages via IL-6/STAT3 and TLR4 Signaling Pathways , 2021, International journal of molecular sciences.

[23]  N. Abu,et al.  Extracellular Vesicles and DAMPs in Cancer: A Mini-Review , 2021, Frontiers in Immunology.

[24]  Tejaswini Appidi,et al.  The role played by bacterial infections in the onset and metastasis of cancer , 2021, Current research in microbial sciences.

[25]  Xueqin Li,et al.  Autophagic secretion of HMGB1 from cancer-associated fibroblasts promotes metastatic potential of non-small cell lung cancer cells via NFκB signaling , 2021, Cell Death & Disease.

[26]  W. Fiedler,et al.  High Mobility Group Box 1 (HMGB1) Induces Toll-Like Receptor 4-Mediated Production of the Immunosuppressive Protein Galectin-9 in Human Cancer Cells , 2021, Frontiers in Immunology.

[27]  Wei Li,et al.  Tumor necrosis: A synergistic consequence of metabolic stress and inflammation , 2021, BioEssays : news and reviews in molecular, cellular and developmental biology.

[28]  J. O’Sullivan,et al.  Identification of TLR2 Signalling Mechanisms Which Contribute to Barrett’s and Oesophageal Adenocarcinoma Disease Progression , 2021, Cancers.

[29]  Wenhui Zhang,et al.  Exosomal HMGB1 derived from hypoxia‐conditioned bone marrow mesenchymal stem cells increases angiogenesis via the JNK/HIF‐1α pathway , 2021, FEBS open bio.

[30]  Xiaolei Shi,et al.  Extracellular HMGB1 promotes CD44 expression in hepatocellular carcinoma via regulating miR-21 , 2021, Aging.

[31]  K. Xiong,et al.  Guidelines for Regulated Cell Death Assays: A Systematic Summary, A Categorical Comparison, A Prospective , 2021, Frontiers in Cell and Developmental Biology.

[32]  Bo Chen,et al.  Prognostic values and immune suppression of the S100A family in pancreatic cancer , 2021, Journal of cellular and molecular medicine.

[33]  Shih-Yi Lin,et al.  Exosomal HMGB1 Promoted Cancer Malignancy , 2021, Cancers.

[34]  J. Zang,et al.  Temozolomide Treatment Induces HMGB1 to Promote the Formation of Glioma Stem Cells via the TLR2/NEAT1/Wnt Pathway in Glioblastoma , 2021, Frontiers in Cell and Developmental Biology.

[35]  G. Chiang,et al.  Imaging Glioblastoma Posttreatment: Progression, Pseudoprogression, Pseudoresponse, Radiation Necrosis. , 2021, Neuroimaging clinics of North America.

[36]  James O. Jones,et al.  Stromal-driven and Amyloid β-dependent induction of neutrophil extracellular traps modulates tumor growth , 2021, Nature Communications.

[37]  W. Han,et al.  S100A8/A9 mediate the reprograming of normal mammary epithelial cells induced by dynamic cell–cell interactions with adjacent breast cancer cells , 2018, Scientific Reports.

[38]  Y. Park,et al.  HMGB1 promotes tumor progression and invasion through HMGB1/TNFR1/NF-κB axis in castration-resistant prostate cancer. , 2021, American journal of cancer research.

[39]  Asma Ahmed,et al.  Targeting immunogenic cell death in cancer , 2020, Molecular oncology.

[40]  A. Engelbrecht,et al.  Serum amyloid A and inflammasome activation: A link to breast cancer progression? , 2020, Cytokine & growth factor reviews.

[41]  Xiaohong Liao,et al.  HMGB1-activated fibroblasts promote breast cancer cells metastasis via RAGE/aerobic glycolysis. , 2020, Neoplasma.

[42]  S. Tavazoie,et al.  Tumoural activation of TLR3–SLIT2 axis in endothelium drives metastasis , 2020, Nature.

[43]  D. Colangelo,et al.  Toll-like receptor 4-mediated inflammation triggered by extracellular IFI16 is enhanced by lipopolysaccharide binding , 2020, PLoS pathogens.

[44]  P. Tsai,et al.  Hepatocellular carcinoma-derived high mobility group box 1 triggers M2 macrophage polarization via a TLR2/NOX2/autophagy axis , 2020, Scientific Reports.

[45]  Nan Li,et al.  Renal cancer-derived exosomes induce tumor immune tolerance by MDSCs-mediated antigen-specific immunosuppression , 2020, Cell Communication and Signaling.

[46]  J. Waldron,et al.  Senescence, Necrosis, and Apoptosis Govern Circulating Cell-free DNA Release Kinetics. , 2020, Cell reports.

[47]  P. Li,et al.  Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma , 2020, BMC Cancer.

[48]  Y. Gan,et al.  HMGN5 promotes IL-6-induced epithelial-mesenchymal transition of bladder cancer by interacting with Hsp27 , 2020, Aging.

[49]  Y. Ni,et al.  Discovery of necrosis avidity of rhein and its applications in necrosis imaging , 2020, Journal of drug targeting.

[50]  Zhijiao Duan,et al.  Self-enforcing HMGB1/NF-κB/HIF-1α Feedback Loop Promotes Cisplatin Resistance in Hepatocellular Carcinoma Cells , 2020, Journal of Cancer.

[51]  F. Di Virgilio,et al.  Purinergic signalling, DAMPs and inflammation. , 2020, American journal of physiology. Cell physiology.

[52]  Y. Ni,et al.  Rhein‐based necrosis‐avid MRI contrast agents for early evaluation of tumor response to microwave ablation therapy , 2019, Magnetic resonance in medicine.

[53]  Kartik Gupta,et al.  Necroptosis in the Pathophysiology of Disease. , 2019, The American journal of pathology.

[54]  Yan Yan,et al.  Hyaluronic Acid Binding to TLR4 Promotes Proliferation and Blocks Apoptosis in Colon Cancer , 2019, Molecular Cancer Therapeutics.

[55]  Wenjin Liang,et al.  HSP27 promotes epithelial-mesenchymal transition through activation of the β-catenin/MMP3 pathway in pancreatic ductal adenocarcinoma cells , 2019, Translational cancer research.

[56]  Panli Li,et al.  Synthesis and Evaluation of Ga-68-Labeled Rhein for Early Assessment of Treatment-Induced Tumor Necrosis , 2019, Molecular Imaging and Biology.

[57]  M. Lotze,et al.  DNA released from neutrophil extracellular traps (NETs) activates pancreatic stellate cells and enhances pancreatic tumor growth , 2019, Oncoimmunology.

[58]  I. Harting,et al.  Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study , 2019, Neurology.

[59]  Nicole M. Chapman,et al.  Upregulation of PD-L1 via HMGB1-Activated IRF3 and NF-κB Contributes to UV Radiation-Induced Immune Suppression. , 2019, Cancer research.

[60]  S. Bornstein,et al.  The pathological features of regulated necrosis , 2019, The Journal of pathology.

[61]  Y. Ni,et al.  Updated developments on molecular imaging and therapeutic strategies directed against necrosis , 2019, Acta pharmaceutica Sinica. B.

[62]  M. Borad,et al.  Hepatocytes direct the formation of a pro-metastatic niche in the liver. , 2019, Nature.

[63]  Hongbing Ma,et al.  High mobility group box 1 promotes radioresistance in esophageal squamous cell carcinoma cell lines by modulating autophagy , 2019, Cell Death & Disease.

[64]  Haitao Zhu,et al.  Toll-like receptor 2 and Toll-like receptor 4 exhibit distinct regulation of cancer cell stemness mediated by cell death-induced high-mobility group box 1 , 2019, EBioMedicine.

[65]  Soohyun Kim,et al.  Serum amyloid A predisposes inflammatory tumor microenvironment in triple negative breast cancer , 2019, Oncotarget.

[66]  R. Oehler,et al.  Circulating Biomarkers of Cell Death. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[67]  Z. Környei,et al.  Mitochondrial DNA in the tumour microenvironment activates neutrophils and is associated with worse outcomes in patients with advanced epithelial ovarian cancer , 2018, British Journal of Cancer.

[68]  Guihua Chen,et al.  Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1+ regulatory B cell expansion , 2018, Journal of Immunotherapy for Cancer.

[69]  M. Berger,et al.  Tissue necrosis and its role in cancer progression , 2018, Oncogene.

[70]  Y. Ni,et al.  Synthesis and Biological Evaluation of Rhein-Based MRI Contrast Agents for in Vivo Visualization of Necrosis. , 2018, Analytical chemistry.

[71]  Thuy-vi Nguyen,et al.  Liquefaction of the Brain following Stroke Shares a Similar Molecular and Morphological Profile with Atherosclerosis and Mediates Secondary Neurodegeneration in an Osteopontin-Dependent Mechanism , 2018, eNeuro.

[72]  Yong Jiang,et al.  Hsp27 regulates epithelial mesenchymal transition, metastasis and proliferation in colorectal carcinoma. , 2018, Oncology letters.

[73]  D. Sharma,et al.  Necroptosis: a regulated inflammatory mode of cell death , 2018, Journal of Neuroinflammation.

[74]  M. Mehrabi,et al.  Active Role of the Necrotic Zone in Desensitization of Hypoxic Macrophages and Regulation of CSC-Fate: A hypothesis , 2018, Front. Oncol..

[75]  M. Lotze,et al.  Extracellular DNA promotes colorectal tumor cell survival after cytotoxic chemotherapy. , 2018, The Journal of surgical research.

[76]  T. Vogl,et al.  Increased Plasma Levels of Danger-Associated Molecular Patterns Are Associated With Immune Suppression and Postoperative Infections in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy , 2018, Front. Immunol..

[77]  Wei Chen,et al.  HSP27 associates with epithelial–mesenchymal transition, stemness and radioresistance of salivary adenoid cystic carcinoma , 2018, Journal of cellular and molecular medicine.

[78]  Hyun Min Jeon,et al.  Regulation of Tumor Progression by Programmed Necrosis , 2018, Oxidative medicine and cellular longevity.

[79]  Frank Höppner,et al.  Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4 , 2016, PloS one.

[80]  K. Nael,et al.  Multiparametric MRI for Differentiation of Radiation Necrosis From Recurrent Tumor in Patients With Treated Glioblastoma. , 2018, AJR. American journal of roentgenology.

[81]  S. Lipton,et al.  Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 , 2018, Cell Death & Differentiation.

[82]  J. Xu,et al.  Downregulation of Calcium-Binding Protein S100A9 Inhibits Hypopharyngeal Cancer Cell Proliferation and Invasion Ability Through Inactivation of NF-κB Signaling. , 2017, Oncology research.

[83]  A. Pandiella,et al.  Neutrophils in cancer: prognostic role and therapeutic strategies , 2017, Molecular Cancer.

[84]  T. Espevik,et al.  Surface TLR 3 expression in metastatic IECs 15410 , 2017 .

[85]  B. Nabet,et al.  Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer , 2017, Cell.

[86]  A. Kulkarni,et al.  Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma , 2017, Molecular Cancer.

[87]  Xiao Wang,et al.  Glucose-derived AGEs promote migration and invasion of colorectal cancer by up-regulating Sp1 expression. , 2017, Biochimica et biophysica acta. General subjects.

[88]  J. Pavelić,et al.  Toll‐like receptor 3 stimulation triggers metabolic reprogramming in pharyngeal cancer cell line through Myc, MAPK, and HIF , 2017, Molecular carcinogenesis.

[89]  Christopher J. Mitchell,et al.  Toward the human cellular microRNAome , 2017, bioRxiv.

[90]  A. Dingemans,et al.  Heat shock protein antagonists in early stage clinical trials for NSCLC , 2017, Expert opinion on investigational drugs.

[91]  Qibing Mei,et al.  Heat Shock Proteins and Cancer. , 2017, Trends in pharmacological sciences.

[92]  Y. Yamamoto,et al.  Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis , 2017, Oncogene.

[93]  R. Huddart,et al.  The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004) , 2017, British Journal of Cancer.

[94]  Y. Ni,et al.  Radiolabeled Rhein as Small-Molecule Necrosis Avid Agents for Imaging of Necrotic Myocardium. , 2017, Analytical chemistry.

[95]  E. Latz,et al.  HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins , 2016, Cellular & Molecular Immunology.

[96]  S. Zeerleder,et al.  Extracellular histones, cell-free DNA, or nucleosomes: differences in immunostimulation , 2016, Cell Death & Disease.

[97]  D. Zagzag,et al.  Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells , 2016, Oncotarget.

[98]  Xuetao Cao,et al.  Tumor Exosomal RNAs Promote Lung Pre-metastatic Niche Formation by Activating Alveolar Epithelial TLR3 to Recruit Neutrophils. , 2016, Cancer cell.

[99]  L. French,et al.  Tumour hypoxia promotes melanoma growth and metastasis via High Mobility Group Box-1 and M2-like macrophages , 2016, Scientific Reports.

[100]  W. ElShamy,et al.  Aggressiveness Niche: Can It Be the Foster Ground for Cancer Metastasis Precursors? , 2016, Stem cells international.

[101]  Hongbo Wang,et al.  S100A4 promotes endometrial cancer progress through epithelial-mesenchymal transition regulation. , 2016, Oncology reports.

[102]  Rihua Zhang,et al.  S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer , 2016, Tumor Biology.

[103]  Karl Kashofer,et al.  Inferring expressed genes by whole-genome sequencing of plasma DNA , 2016, Nature Genetics.

[104]  R. Muschel,et al.  Tumor-infiltrating monocytes/macrophages promote tumor invasion and migration by upregulating S100A8 and S100A9 expression in cancer cells , 2016, Oncogene.

[105]  M. Lotze,et al.  Until Death Do Us Part: Necrosis and Oxidation Promote the Tumor Microenvironment , 2016, Transfusion Medicine and Hemotherapy.

[106]  Jens Pietzsch,et al.  Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells , 2016, Journal of cellular and molecular medicine.

[107]  Da Li,et al.  Effects of receptor for advanced glycation endproducts on microvessel formation in endometrial cancer , 2016, BMC Cancer.

[108]  Young Hun Kim,et al.  N-linked glycosylation plays a crucial role in the secretion of HMGB1 , 2016, Journal of Cell Science.

[109]  P. Pickkers,et al.  Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients , 2016, Intensive Care Medicine.

[110]  J. Seuntjens,et al.  The Role of HMGB1 in Radioresistance of Bladder Cancer , 2015, Molecular Cancer Therapeutics.

[111]  J. Mayerson,et al.  Osteosarcoma: A Meta-Analysis and Review of the Literature. , 2015, American journal of orthopedics.

[112]  M. Lotze,et al.  DAMPs, ageing, and cancer: The ‘DAMP Hypothesis’ , 2015, Ageing Research Reviews.

[113]  G. Mælandsmo,et al.  Metabolic reprogramming supports the invasive phenotype in malignant melanoma. , 2015, Cancer letters.

[114]  Yi-Wen Chen,et al.  Elevated S100A9 expression in tumor stroma functions as an early recurrence marker for early-stage oral cancer patients through increased tumor cell invasion, angiogenesis, macrophage recruitment and interleukin-6 production , 2015, Oncotarget.

[115]  P. Delvenne,et al.  HMGB1 secretion during cervical carcinogenesis promotes the acquisition of a tolerogenic functionality by plasmacytoid dendritic cells , 2015, International journal of cancer.

[116]  M. Lotze,et al.  Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9. , 2015, Journal of hepatology.

[117]  Jingyuan Fang,et al.  Redox status of high-mobility group box 1 performs a dual role in angiogenesis of colorectal carcinoma , 2015, Journal of cellular and molecular medicine.

[118]  R. Wu,et al.  S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways. , 2015, Experimental cell research.

[119]  S. Pastorino,et al.  Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression , 2015, Cell Death and Disease.

[120]  Ling Zhou,et al.  Increased HMGB1 and cleaved caspase-3 stimulate the proliferation of tumor cells and are correlated with the poor prognosis in colorectal cancer , 2015, Journal of experimental & clinical cancer research : CR.

[121]  Xianjun Zhu,et al.  Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma , 2015, Oncotarget.

[122]  S. Ghavami,et al.  RAGE Mediates the Pro-Migratory Response of Extracellular S100A4 in Human Thyroid Cancer Cells. , 2015, Thyroid : official journal of the American Thyroid Association.

[123]  Hai-hua Luo,et al.  AB044. AGE/RAGE/Akt pathway contributes to prostate cancer cell proliferation by promoting Rb phosphorylation and degradation , 2015, American journal of cancer research.

[124]  Zhuo Zhang,et al.  S100A4 expression is closely linked to genesis and progression of glioma by regulating proliferation, apoptosis, migration and invasion. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[125]  M. Gleave,et al.  Hsp27 regulates EGF/β‐catenin mediated epithelial to mesenchymal transition in prostate cancer , 2015, International journal of cancer.

[126]  Michael C. Ostrowski,et al.  RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment. , 2015, Cancer research.

[127]  V. Wong,et al.  Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients , 2015, Proceedings of the National Academy of Sciences.

[128]  Xiao-hou Wu,et al.  Exosomal Hsp70 mediates immunosuppressive activity of the myeloid-derived suppressor cells via phosphorylation of Stat3 , 2015, Medical Oncology.

[129]  F. Watt,et al.  Innate sensing of microbial products promotes wound-induced skin cancer , 2015, Nature Communications.

[130]  T. Zima,et al.  RAGE and its ligands in cancer - culprits, biomarkers, or therapeutic targets? , 2015, Neoplasma.

[131]  Jinyong Peng,et al.  Novel Role of Resveratrol: Suppression of High-Mobility Group Protein Box 1 Nucleocytoplasmic Translocation by the Upregulation of Sirtuin 1 in Sepsis-Induced Liver Injury , 2014, Shock.

[132]  K. Tracey,et al.  HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells. , 2014, Cancer research.

[133]  W. Neuhofer,et al.  NFAT5-mediated expression of S100A4 contributes to proliferation and migration of renal carcinoma cells , 2014, Front. Physiol..

[134]  D. Tang,et al.  Release and activity of histone in diseases , 2014, Cell Death and Disease.

[135]  P. Stattin,et al.  High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome. , 2014, European journal of cancer.

[136]  Haichao Wang,et al.  PKM2 Regulates the Warburg Effect and Promotes HMGB1 Release in Sepsis , 2014, Nature Communications.

[137]  Minho Chae,et al.  Serum amyloid A3 exacerbates cancer by enhancing the suppressive capacity of myeloid‐derived suppressor cells via TLR2‐dependent STAT3 activation , 2014, European journal of immunology.

[138]  A. Ochiai,et al.  High Mobility Group Box1 (HMGB1) released from cancer cells induces the expression of pro‐inflammatory cytokines in peritoneal fibroblasts , 2014, Pathology international.

[139]  A. Horii,et al.  S100A4 is frequently overexpressed in lung cancer cells and promotes cell growth and cell motility. , 2014, Biochemical and biophysical research communications.

[140]  K. Tracey,et al.  Intracellular Hmgb1 inhibits inflammatory nucleosome release and limits acute pancreatitis in mice. , 2014, Gastroenterology.

[141]  Tianshu Yang,et al.  High‐mobility group box‐1 and its role in angiogenesis , 2014, Journal of leukocyte biology.

[142]  T. Clancy,et al.  Metastasis-associated protein S100A4 induces a network of inflammatory cytokines that activate stromal cells to acquire pro-tumorigenic properties. , 2014, Cancer letters.

[143]  K. Syrigos,et al.  Necrosis and apoptotic index as prognostic factors in non-small cell lung carcinoma: a review , 2014, SpringerPlus.

[144]  F. Di Virgilio,et al.  ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment , 2014, Cell Death and Disease.

[145]  Wei Li,et al.  Nucleosome loss leads to global transcriptional up-regulation and genomic instability during yeast aging , 2014, Genes & development.

[146]  I. Pedrosa,et al.  Tumor necrosis on magnetic resonance imaging correlates with aggressive histology and disease progression in clear cell renal cell carcinoma. , 2014, Clinical genitourinary cancer.

[147]  Haichao Wang,et al.  The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics , 2014, Oncogene.

[148]  P. Vandenabeele,et al.  Regulated necrosis: the expanding network of non-apoptotic cell death pathways , 2014, Nature Reviews Molecular Cell Biology.

[149]  B. Viollet,et al.  TIM-4 glycoprotein-mediated degradation of dying tumor cells by autophagy leads to reduced antigen presentation and increased immune tolerance. , 2013, Immunity.

[150]  H. Nie,et al.  Stimulation of TLR4 by LMW-HA Induces Metastasis in Human Papillary Thyroid Carcinoma through CXCR7 , 2013, Clinical & developmental immunology.

[151]  L. Antonioli,et al.  Immunity, inflammation and cancer: a leading role for adenosine , 2013, Nature Reviews Cancer.

[152]  Laura Conti,et al.  The noninflammatory role of high mobility group box 1/toll‐like receptor 2 axis in the self‐renewal of mammary cancer stem cells , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[153]  Jianling Xie,et al.  Cellular signalling of the receptor for advanced glycation end products (RAGE). , 2013, Cellular signalling.

[154]  M. Gleave,et al.  Extracellular HSP27 mediates angiogenesis through Toll‐like receptor 3 , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[155]  Hong-Yang Wang,et al.  p53 promotes inflammation-associated hepatocarcinogenesis by inducing HMGB1 release. , 2013, Journal of hepatology.

[156]  F. Motoi,et al.  The Expression of S100A4 in Human Pancreatic Cancer Is Associated With Invasion , 2013, Pancreas.

[157]  Angelika Bierhaus,et al.  Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation‐associated liver carcinogenesis in mice , 2013, Hepatology.

[158]  M. Lotze,et al.  HMGB1 in Cancer: Good, Bad, or Both? , 2013, Clinical Cancer Research.

[159]  M. Gleave,et al.  Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer. , 2013, Cancer research.

[160]  Q. Shi,et al.  Correction: S100A8 and S100A9 Are Associated with Colorectal Carcinoma Progression and Contribute to Colorectal Carcinoma Cell Survival and Migration via Wnt/β-Catenin Pathway , 2013, PLoS ONE.

[161]  M. Markey,et al.  Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies. , 2013, Neuro-oncology.

[162]  R. Donato,et al.  Functions of S100 proteins. , 2012, Current molecular medicine.

[163]  U. Andersson,et al.  TLR activation regulates damage‐associated molecular pattern isoforms released during pyroptosis , 2012, The EMBO journal.

[164]  K. Ishii,et al.  Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccination , 2012, Front. Cell. Inf. Microbio..

[165]  F. Chan,et al.  Detection of necrosis by release of lactate dehydrogenase activity. , 2013, Methods in molecular biology.

[166]  M. Tangney,et al.  Bacteria and tumours: causative agents or opportunistic inhabitants? , 2013, Infectious Agents and Cancer.

[167]  Qing Li,et al.  Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling , 2012, The Journal of experimental medicine.

[168]  M. Hance,et al.  Secreted Hsp90 Is a Novel Regulator of the Epithelial to Mesenchymal Transition (EMT) in Prostate Cancer* , 2012, The Journal of Biological Chemistry.

[169]  A. Westendorf,et al.  HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells. , 2012, International immunology.

[170]  H. Yoshiyama,et al.  Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1 , 2012, Nature Immunology.

[171]  A. Borkowski,et al.  Ultraviolet radiation damages self noncoding RNA and is detected by TLR3 , 2012, Nature Medicine.

[172]  J. Fajkus,et al.  HMGB1 gene knockout in mouse embryonic fibroblasts results in reduced telomerase activity and telomere dysfunction , 2012, Chromosoma.

[173]  Kazuyuki Sugahara,et al.  Receptor for Advanced Glycation End Products (RAGE) Functions as Receptor for Specific Sulfated Glycosaminoglycans, and Anti-RAGE Antibody or Sulfated Glycosaminoglycans Delivered in Vivo Inhibit Pulmonary Metastasis of Tumor Cells* , 2012, The Journal of Biological Chemistry.

[174]  D. Crawford,et al.  Degraded mitochondrial DNA is a newly identified subtype of the damage associated molecular pattern (DAMP) family and possible trigger of neurodegeneration. , 2012, Journal of Alzheimer's disease : JAD.

[175]  G. Fritz RAGE: a single receptor fits multiple ligands. , 2011, Trends in biochemical sciences.

[176]  D. McMillan,et al.  The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review. , 2011, Future oncology.

[177]  D. Golenbock,et al.  Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. , 2011, Immunity.

[178]  D. Jay,et al.  Extracellular Heat Shock Protein (Hsp)70 and Hsp90α Assist in Matrix Metalloproteinase-2 Activation and Breast Cancer Cell Migration and Invasion , 2011, PloS one.

[179]  A. C. Könner,et al.  Toll-like receptors: linking inflammation to metabolism , 2011, Trends in Endocrinology & Metabolism.

[180]  K. Tracey,et al.  Endogenous HMGB1 regulates autophagy , 2010, The Journal of cell biology.

[181]  Samuel H. Wilson,et al.  HMGB1: roles in base excision repair and related function. , 2010, Biochimica et biophysica acta.

[182]  V. Gabai,et al.  Mechanisms of tumor cell necrosis. , 2010, Current pharmaceutical design.

[183]  J. Tschopp,et al.  Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors , 2009, Nature Medicine.

[184]  M. Omary,et al.  Toward unraveling the complexity of simple epithelial keratins in human disease. , 2009, The Journal of clinical investigation.

[185]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[186]  Haichao Wang,et al.  Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function. , 2009, American journal of respiratory cell and molecular biology.

[187]  F. Santilli,et al.  Soluble forms of RAGE in human diseases: clinical and therapeutical implications. , 2009, Current medicinal chemistry.

[188]  R. Medzhitov,et al.  Toll-like receptors and cancer , 2009, Nature Reviews Cancer.

[189]  Hiroyuki Aburatani,et al.  The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase , 2008, Nature Cell Biology.

[190]  D. Foell,et al.  Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells1 , 2008, The Journal of Immunology.

[191]  W. Nacken,et al.  Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein , 2008, The Journal of experimental medicine.

[192]  A. Enk,et al.  RAGE signaling sustains inflammation and promotes tumor development , 2008, The Journal of experimental medicine.

[193]  J. Sleeman,et al.  Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4 , 2008, Experimental dermatology.

[194]  S. Fan,et al.  Growth suppression and radiosensitivity increase by HMGB1 in breast cancer , 2007, Acta Pharmacologica Sinica.

[195]  Laurence Zitvogel,et al.  Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy , 2007, Nature Medicine.

[196]  V. Kuchroo,et al.  Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression , 2007, The Journal of experimental medicine.

[197]  I. Ito,et al.  Post-translational Methylation of High Mobility Group Box 1 (HMGB1) Causes Its Cytoplasmic Localization in Neutrophils* , 2007, Journal of Biological Chemistry.

[198]  Haichao Wang,et al.  Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1 , 2007, Journal of leukocyte biology.

[199]  L. Zitvogel,et al.  Calreticulin exposure dictates the immunogenicity of cancer cell death , 2007, Nature Medicine.

[200]  D. Pisetsky,et al.  The extracellular release of HMGB1 during apoptotic cell death. , 2006, American journal of physiology. Cell physiology.

[201]  J. Flier,et al.  TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.

[202]  James J. Lee,et al.  Pivotal Advance: Eosinophil infiltration of solid tumors is an early and persistent inflammatory host response , 2006, Journal of leukocyte biology.

[203]  M. Bours,et al.  Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. , 2006, Pharmacology & therapeutics.

[204]  C. Coban,et al.  A Toll-like receptor–independent antiviral response induced by double-stranded B-form DNA , 2006, Nature Immunology.

[205]  L. Whitesell,et al.  Altered Hsp90 function in cancer: a unique therapeutic opportunity. , 2004, Molecular cancer therapeutics.

[206]  D. Weissman,et al.  mRNA Is an Endogenous Ligand for Toll-like Receptor 3* , 2004, Journal of Biological Chemistry.

[207]  G. Kramer,et al.  Differentiation between Cell Death Modes Using Measurements of Different Soluble Forms of Extracellular Cytokeratin 18 , 2004, Cancer Research.

[208]  Tiziana Bonaldi,et al.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion , 2003, The EMBO journal.

[209]  R. Ye,et al.  Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. , 2003, Blood.

[210]  J Martin Brown,et al.  Tumor Microenvironment and the Response to Anticancer Therapy , 2002, Cancer biology & therapy.

[211]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.

[212]  A. Aguzzi,et al.  The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice , 1999, Nature Genetics.